SLC7A11 and non-small cell lung carcinoma: Overall, LAT1, ASCT2, and xCT are overexpressed through oncogenic, hypoxic, and epigenetic programs, support metabolic and redox demands, and predict poor outcomes, thereby establishing them as both biomarkers and therapeutic targets in NSCLC.